Hims & Hers CEO says FTC lawsuit misunderstands how the company works

Hims & Hers CEO Andrew Dudum stated that the Federal Trade Commission's lawsuit against the company is based on a misunderstanding of its operations, according to an interview with CNBC. The lawsuit involves the company's compounded GLP-1 drugs and its use of artificial intelligence. Dudum did not specify which aspects of the FTC's claims he disputed.

Next story